Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis
Anne I. Hahn,Duco T. Mülder,Robert J. Huang,Margaret J. Zhou,Benjamin Blake,Omonefe Omofuma,John D. Murphy,Daniela S. Gutiérrez-Torres,Ann G. Zauber,James F. O’Mahony,M. Constanza Camargo,Uri Ladabaum,Jennifer M. Yeh,Chin Hur,Iris Lansdorp-Vogelaar,Reinier Meester,Monika Laszkowska
DOI: https://doi.org/10.1016/j.cgh.2024.09.003
IF: 13.576
2024-10-03
Clinical Gastroenterology and Hepatology
Abstract:Background and Aims Whether gastric cancer (GC) precursor lesions progress to invasive cancer at similar rates globally remains unknown. We conducted a systematic review and meta-analysis to determine the progression of precursor lesions to GC in countries with low versus medium/high incidence. Methods We searched relevant databases for studies reporting the progression of endoscopically confirmed precursor lesions to GC. Studies were stratified by low (<6 per 100,000) or medium/high (≥6 per 100,000) GC incidence countries. Random-effects models were used to estimate the progression rates of atrophic gastritis (AG), intestinal metaplasia (IM), and dysplasia to GC per 1,000 person-years. Results Among the 5,829 studies identified, 44 met our inclusion criteria. The global pooled estimates of the progression rate per 1,000 person-years were 2.09 (95% CI 1.46-2.99), 2.89 (2.03-4.11) and 10.09 (5.23-19.49) for AG, IM, and dysplasia respectively. The estimated progression rates per 1,000 person-years for low versus medium/high GC incidence countries, respectively, were 0.97 (0.86-1.10) vs. 2.47 (1.70-2.99) for AG (p<0.01); 2.37 (1.43-3.92) vs. 3.47 (2.13-5.65) for IM (p=0.29); and 5.51 (2.92-10.39) vs. 14.80 (5.87-37.28) for dysplasia (p=0.08). There were no differences for progression of AG between groups when high quality studies were compared. Conclusion Similar progression rates of IM and dysplasia were observed among low and medium/high GC incidence countries. This suggests that the potential benefits of surveillance for these lesions in low-risk regions may be comparable to those of population-wide interventions in high-risk regions. Further prospective studies are needed to confirm these findings and inform global screening and surveillance guidelines.
gastroenterology & hepatology